|
Volumn 17, Issue 7, 2001, Pages 631-635
|
An in vivo model for HIV resistance development
b
MEDIVIR AB
(Sweden)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COMPLEMENTARY DNA;
NEVIRAPINE;
RNA DIRECTED DNA POLYMERASE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
VIRUS RNA;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG TRANSFORMATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IN VIVO STUDY;
MONKEY;
MONKEY DISEASE;
MONOTHERAPY;
NONHUMAN;
PRIORITY JOURNAL;
SIMIAN IMMUNODEFICIENCY VIRUS;
VIRUS HYBRID;
VIRUS INFECTION;
VIRUS LOAD;
VIRUS MUTATION;
VIRUS RESISTANCE;
ANIMALS;
CHIMERA;
DISEASE MODELS, ANIMAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG RESISTANCE;
HIV INFECTIONS;
HIV-1;
HIV-1 REVERSE TRANSCRIPTASE;
MACACA FASCICULARIS;
NEVIRAPINE;
REVERSE TRANSCRIPTASE INHIBITORS;
RNA, VIRAL;
SIMIAN IMMUNODEFICIENCY VIRUS;
|
EID: 0034941722
PISSN: 08892229
EISSN: None
Source Type: Journal
DOI: 10.1089/088922201300119734 Document Type: Article |
Times cited : (20)
|
References (13)
|